PTV's Dr Fintan Walton interviews top executives from leading pharmaceutical and biotechnology companies. PharmaTelevision News Review is available on PharmaTelevision to registered users. Register now to get access!

News Review Latest

News Review Archive
Scroll: Previous
Treeway: Pioneering
AstraZeneca
Why Genentech
Can multi- DARPins
Immunovia:
Can measuring DNA
The story of how UK
Contravir:
Daniela Bellomo, TT
Can Sunergos
Cell and Gene
Biotech and Money
Isis Innovation:
Cambridge
Cancer Research
What makes PsiOxus’
How to harness
Jason Coloma,
Axel Hoos, GSK:
argenx and LEO
Building the bio
Can Ellume’s unique
Bill Primrose, CEO,
Sarah Haywood, CEO,
Chris Mayo,
Paul V. Drohan, CEO
Katya Ascher,
Richard Mason,
Zahid Latif, Head
Jane Dancer, CBO,
Dr. Thomas Mander
Is Cortisol
How Benitec’s
Chris Haskell, Head
Can GSK and Altius
BerGenBio: How EMT
The 'Two Cylinder'
A need for a new
What’s behind
How Sienna Cancer
Can Opal
Laurent Levy, CEO,
Collagen-based cell
How the Biotech
The strategy behind
How the Oslo Cancer
Can ganaxolone
Sprint Biosciences:
How Stockholm
Mevia: How printed
A positive approach
How 18-MC is
MVIC: A one-stop
Gene-Therapy
The right drug, to
Karolinska
AMRA: Facilitating
Is the future of
How Galapagos is
The story behind
Is Targovax going
The NASDAQ capitals
Does your
Pledpharma, helping
Kancera: Focusing
Harriet Fear, One
Jim Greenwood CEO
Steve Bates BIA:
Anthony Holmes,
Neill Moray
Sanofi Pasteur:
Why R&D Innovation
Saroj Velamakanni,
Sven Lee: How
Mike Riley,
Reza Moridi,
Mark Noguchi,
How to solve a key
Is it possible to
Aidan Courtney,
Enrico Bastianelli,
David Phillips,
Holoclar® - The
Why Pluristem
Antoine Papiernik,
Kevin Johnson,
Personalised
Janssen Canada
Developing
Discovering the
F.I.R.S.T.™ - a
Gregory Bonfiglio,
Mattias Johansson,
Save the Cord
Mattias Nystrom,
How Inflection
Dedicated to
Addressing the
It's all about
Driving success by
Build on
AM Pharma and
Why listening to
Why Boehringer
Mike Capaldi,
Alessandro Padova,
Award winning
Are we on the verge
Marco Mohwinckel,
Preparation and
Have we reached a
Funding, supporting
Is evergreen
Can Cell Therapy
Why Lord Digby
Neil Darkes and
Nanobodies-
Dame Sally Davies
How to divide and
Uncovering cutting
Premaitha: changing
U-CAN Project-
Atomo Diagnostics:
Developing novel
Dr Rob Phillips,
Ian Edvalson,
Professor Ira
Professor Frank
How are Polyplus
How close are
Deborah Rathjen,
Australia ranked
Could Phaxan™
Claire Skentelbery,
OssDsign – The New
Dave Pinnington,
Albert van Eijk,
Kay Rispeter,
Irina Osovskaya,
Mike Bellis Pfizer
Tim White,
Felix Jackson,
Kaush Gandhi,
Delivering
How film making is
Fighting Prostate
Applying legal
Beyond antibodies.
Connecting brain
A Dedicated
Why choose Norway
Can PledPharma
Breakthrough
Tim Herpin,
Genentech
Genentech:Napoleone
Genzyme, Stephanie
J&J Innovation,
How do you take
How are ValiRx
“Can cancer cells
AstraZeneca, Shaun
TransCelerate
Marks & Clerk,
How are Sanofi
Is Abzena the new
How BerGen Bio are
How would you spend
What is the
Sunil Shah, CEO,
Can J&J's novel
Regina Hodits,
Christoph Schmidt,
Is TxCell close to
Harnessing J&J's
Pfizer explains
Biotech turns
DuBiotech - Growing
Transforming
Clare Wareing,
The Importance of
Putting the patient
Accelerating the
A front door to the
Creating an urgency
Why Pharma has to
Collaboration - the
Carlos de Sousa,
Changing the rules
Highlighting UK
Why Flanders is a
AstraZeneca:Shaun
Zoetis, a world
A quicker way to
Two Becomes One-
Valeria Uribe,
Converting medical
A novel approach to
Providing a high
Developing
Dedicated to
Jack Bobo, Senior
GW Pharmaceuticals,
Global CEO
Getting closer to
Rainmaker, the
Boehringer
Pharma Innovation
Chris Nave, Brandon
John Holaday, CEO,
Marc Goemans, DSM
Lee Rodney,
Hon. Ian Walker MP
Barry Thomas,
Monika Richter,
Rob de Ree, CEO,
Johannes Sarx, LISA
Katherine Cohen,
David Malek,
Tsipi Keren-Lehrer,
Mel Billingsly,
Kenneth Chien,
Evan Siegel, Ground
Genentech, Kevin
Ontoforce. Peter
Fintan Walton &
Sam Fazeli,
Dr Stelios
BioPeople, Sophie
Noxxon, Aram
AusBiotech, Anna
Bionomics, Deborah
PharmaSynth, Alex
Jonas Ekstrand,
Piyush Unalkat,
Claire Dorrian,
Colin
Award winning
Laurent Levy, CEO,
Dr Ryan Donnelly,
Helen Khulman, Lead
Award winning
Hunt Biosciences,
FundedByMe Equity,
Kevin Johnson,
Michele Ollier,
Anders Ekblom,
Hugh Salter, Head,
F-star, John
Ben Miles,
Lein Applied
NanoSight finds
BIO:The continuing
Kit Malthouse,
Immunocore; Working
Eagle Genomics:
BioIndustry
Johnson & Johnson
Anglonordic Biotech
BerGenBio: Richard
Inflection
Smerud Medical
Forbion’s General
Grant Thornton:
Q Chip: Tim Sparey.
Ockham Oncology’s
EUSA Pharma: Bryan
Avillion: Lewis
Karus Therapeutics
Andrew Casey
Denovo Biomarkers:
Takeda Ventures
Oxford Gene
Creabilis: Eliot
Horizon Discovery &
Life Sciences
Sustainable
Genzyme: Rogerio
KaloBios: David
Johnson & Johnson
Geropharm: Petr
Roche: Sophie
Ysios Capital:
Advanced Cell
Roche: Stefan
Biocat: Montserrat
Telormedix: Johanna
e-Therapeutics:
Genentech: Mike
GSK & Avalon
CIRM: Elona Baum.
AstraZeneca: Morten
TVM Capital: Axel
EMD Serono:
Almirall: Jordi
Aicuris: Prof.
Genmedica: Alec
Johnson & Johnson:
Bayer Healthcare:
Catalent: Sven
Geoff Brooke,
George Millstien,
EBD Group: Carola
Government of
Gene Signal: Eric
Trophos: Christine
MDSL International:
Sunshine Heart :
Takeda: Carlos De
Virttu Biologics:
Alzheimer's
Massachusetts Life
UniQuest : Dr Dean
Innovacell:
Genetic Alliance
Merck & Co: Gregory
Prosensa: Luc
Forbion Capital
Evotec: Cord
Promethera: Eric
DSM Biologics:
Genentech:
AstraZeneca: Tim
Roche: Shafique
Bionomics: Deborah
AusBiotech: Anna
Galapagos: Onno Van
Novo Nordisk :
Forbion Capital
Procter & Gamble:
Allied Healthcare
BaselArea Economic
MacuClear :Philip
Carnot
Tigenix: Maria
AstraZeneca: Shaun
Nina Dudnick,
Anders Ekblom;
TVG: Robert Lee
Hans Preusting:
Reid Leonard :
David de
Holger
Carola Schropp, EBD
Tom Shepherd ,
Robert Coughlin:
The Importance of
Michael Poole,
Garry Neil,
GSK: Ian Tomlinson
Puerto Rico
John Fraher,
Pfizer: Biosimilars
Janssen Research &
Janssen Research &
Johnson & Johnson,
BioCatalyst:
Millennium:Looking
Pear Pugh
Astellas & Merck &
Roche Partnering:
Apex-Brasil:
Genzyme: What Makes
Bionic Vision
DSM
TT Factor: Seeking
BVGH: Bringing
Immunovaccine:
Cytheris:
Medimmune: Joining
AC Immune: Second
Amakem: Targeting
Horizon Discovery;
Index Ventures:
Apposite Capital:
Almac Discovery:
Molecular Partners
4-Antibody:
Sutro Biopharma:
BioLineRx: 'Bench
MPM Capital: Good
Innovation- Merck's
Galapagos: 3
Aram Mangasarian
ProtAffin: A new
Genentech
Technology to
Why AstraZeneca
R&D and Business
Award Winning
Deal Making in
Deal Making in
Deal Making in
Index Ventures, GSK
Great Science
Peter York and Paul
Sunshine Heart:
Brandon Capital
QRx Pharma Ltd:
Polytherics close
BIOTECanada: Peter
CM Capital: Mark
Prosensa: Luc
Benitec: Peter
Bionomics Ltd:
OrthoCell: Paul
GBS Venture
Molmed: Holger
Biosceptre: Cliff
Novo Nordisk: Tomas
Hybrigenics:
Gallus
AstraZeneca: Geoff
AusBiotech: Anna
TVG: Robert
European
BioVista Inc.
Children's Hospital
Astex
AstraZeneca: Shaun
Spinifex: CEO, Tom
Asmacure. CEO,
Genentech Inc:
BioCity CEO, Glenn
Pfizer Inc's Polly
BioBDx: Byron
Kymab: Tom Shepherd
The Promise of
Karin Bryskhe, CEO
Bob Coughlin, CEO
BIA Chairman, Tim
GSK: Mark Wilson
Dr. Jay Tischfield
William Prather, of
Cellzome: Tim
BiondVax
Invida: John Graham
Pfizer: Doug
Merck Research
IDA Ireland: Dave
Syntaxin: Melanie
DSM
Genentech`s James
Roche, Dan
The pharma and drug
Janssen
Psioxus CEO John
BayBio CEO Gail
Konstantinos
Patrick O'Reilley,
Alan Lewis, 2011
Anne Lane,
John Noble,
Francis Gurry,
Anthony Venturino,
Linda Chao of
Blair Jackson of
David Chiswell, CEO
Olivier Litzka of
Marc Van de Craen
Naiyin Wang
Roel Bulthuis of
Bryan Morton tells
Martin Heidecker of
Sunil Shah
Manuel
Martin Buckland
Takeda make a
Greg Wiederrecht,
Damian Maron, CEO
Tim Sparey, Head of
Gregory Moss Smith,
ACT: Accelerating
Henning Afflerbach,
Phillippe
Marco Boorsma
Roche's Approach to
Remi Delansorne,
Kevin Johnson,
Clifford Stocks
Ian Nicholson of
Joaquin Gomez of
Rentschler
BioIndustry
Francesco De
Lilly Ventures: Ed
Kerstin Valinder
Immutep`s
Telormedix’s
Christian Zahnd
Finn Benned Hansen
Luc Dochez on why
Christelle Dagoneau
AusBio Conference
Susan Graff talks
China and Korea -
QRX Pharma: Finding
Andrew Bray
Deborah Rathjen
BioAngels: Dr John
AusBioTech: Dr Anna
BIO: Growth of
Merck & Co and
Immunovaccine`s
BioServe: One of
REGiMMUNE:
LivTech Inc: Dr.
JBA: Setsuo
Canbas: Takumi
MGH & BU: Steven
Roche Partnering:
MassBio: Robert
Chiome: Masa
EDB Group: Carola
Bioniche: Graeme
Seeding Labs: Nina
SIOGEN Biotech:
PharmaVentures
PharmaVentures
PharmaVentures CEO,
Cerenis
BIO Ventures for
London Technology
Reed Smith LLP:
Cancer Research
Bayer Schering
Roche & Genentech:
BIO: Jim Greenwood
DSM Biologics:
DSM
DSM
CellCoTec: Ian
KryoTrans
Epistem: Matthew
Almac Sciences:
Domainex Ltd:
Takeda Research
Deals in a Downturn
Paul Capital
PolyTherics Ltd:
KBC Peel Hunt: The
ChinaBio LLC:
ASEBIO:
European Patent
Orion Corporation:
Aisling Capital:
BioCat: Funding and
Novartis Venture
Amgen Spain:
Invest in Spain:
Genoma España: The
Merck & Co.:
TVM Capital:
Roche: Deals,
GlaxoSmithKline:
Galapagos:
Argos Therapeutics:
Living Cell
Ernst & Young: The
Novartis:
J.P. Morgan: The
Merck Serono:
Minomic: Innovative
Biota: Success With
Starpharma:
Manitoba STEM:
BIOTECanada: Why
Intersuisse
GBS Venture
Roche: Partnering
Bailard
PlantBio Trust:
Eli Lilly: The
The Hon Peter
Paul Cheever
Pfizer: An Ideal
Biosceptre: A New
Biotechnology in
Roche: What they
The Ewing Marion
Rexahn
Sutro Biopharma:
American Gene
The Michael J Fox
BioBay: Using
Fountain Medical
BayBio's year and
ChinaBio LLC: China
Approaching
Moving forward:
Aisling Capital:
Genentech: Becoming
MPM Capital: The
Celtic Pharma:
Thiakis’ origins,
TVM Capital:
Chroma
Stemgent: Fate,
MolMed’s Key
BIA: Bringing
BIA: Funding and
Part 1: Is the
Part 2: Is the
Part 1: The Golden
Part 2: The Golden
Merck Serono
Part 1: 2009 and
Part 2: 2009 and
Johnson & Johnson:
Pfizer’s
The New Merck
BIO and 2009 – the
InDex
sanofi-aventis’ New
Roche:Genentech
Part 1: The future
Part 2: The future
Part 3: The future
1. Out-licensing by
2. Out-licensing by
The credit crunch
The Gateway to
Immunocore &
The Wellcome Trust:
Biotica’s Balancing
Reinventing Roche’s
Burnham’s
Compugen’s Powers
Idera
Nicast’s New
GlobeImmune’s
SeraCare’s
KaloBios’
Hadasit
Oncolytics Biotech:
What’s Next For
How SkyePharma
The Allergan Model
Menarini’s Global
Will GSK’s
The Diversification
Pfizer and Wyeth’s
The EBD Group's
Genera Biosystems:
China’s Emergence
The Future of
Bristol-Myers
Biota Focuses on
Starpharma’s
Merck Goes Back to
Roche Seeks Out CNS
New Pharma Partner
Pfizer’s Investment
Was Biotech Failed
AusBiotech Evolves
How Government Can
Victorian
Takeda Strengthens
How Do Eli Lilly &
Oxford BioMedica:
Sir Michael Rawlins
Early Stage Spin
Novacta Biosystems:
Recent Deals
Cancer Research
PharmaVentures:
DuBiotech: The
Antisoma Plc
InterMed Discovery:
EGEN: A Research
Cellzome and
Xceleron: Changing
Polyphor Ltd:
Stemgent: Supplying
EBD Group: Carola
Artisan Draws
La Jolla
Paul Capital
BioInvent’s Deal
EuropaBio: Working
BIO: The Future
Neuropharma: A New
Karus Therapeutics:
ValiRx: Bioscience
Mercury
AM-Pharma:
The GI Company:
Takeda Research
Maryland DBED: Will
Addex
Apposite Capital:
Archimedes Pharma:
EUSA Pharma:
Bird & Bird: A View
Synta
Novarix: Interview
NovaQuest:
London Genetics:
Xanthus: Evolving
Uniseed Management:
Tissue Therapies’
Speedel’s Renin
Micromet: From
BayBio: Impact of
AusBiotech: An
Ablynx’s Success
Alchemia: Drug
Stem Cell Sciences:
Phylogica: Business
Merck & Co.:
KaloBios: The
IEDC: Indiana: A
GE Healthcare
MorphoSys:
McKenna Long &
eG Capital:
Simmons & Simmons:
Johnson & Johnson:
Bristol-Myers
Sofinnova Partners:
Piramed Pharma: The
Ganymed Pharma:
Faust
Eli Lilly & Co.:
Oxford Technology
PharmaDeals
Novosom: Strategies
BIOCOM: Challenges
Midatech: The Story
Gene Bridges: Life
Borean Pharma:
Novartis Breaks the
Lexicon
Genentech: Driven
Bingham McCutchen:
F. Hoffmann-La
Oxford BioMedica:
BIO: Issues and
The Pharmaceutical
NicOx: The Rise of
Celltech: The Three
Celltech: The Birth
BioXcel
The Pharmaceutical
ZymoGenetics:
Sareum and
Ipso Ventures
Implicit
Synosia
Nektar
Glide Pharma: The
Johnson & Johnson:
PharmaTelevision:
Meet the Experts
Meet the Experts:
Speedel: Dr Alice
BayBio: Matthew
Zogenix: Stephen
F. Hoffmann-La
MorphoSys: Dr Simon
Biota: Peter Cook,
AstraZeneca: Rob
Meet the Experts:
Simcere
Galapagos: Onno van
Evotec: Dr Mark
Archimedes Pharma:
Meet the Experts:
Meet the Experts:
ZymoGenetics: 25
Meet the Experts:
Scroll: Next
PTV News Review Feed:
News Archive
Scroll: Previous
Changing
Glaxo Study
Sanofi Deal
News Headlines
Parkinson Partners
France Cuts
Novartis Trials
News Headlines
UK Biotechs
Covidien Purchase
Amgen Advances
News Headlines
Positive Data
Approval Denied
Novo Leads Fight
News Headlines
Perrigo Rapped
Roche Warning
Sanofi Venture
News Headlines
Genzyme Battle
Indian Advance
Novartis Setback
News Headlines
Biotech Bonanza
Avila Partnership
Curing Hep C
News Headlines
Spending Spree
Targeting China
Gaucher App
News Headlines
Celldex Trials
Biotech Tax
New Drugs From Old
News Headlines
Aspen targets Sigma
Equipment Drive
Abbott Acquisition
News Headlines
GW Pharmaceuticals
Novartis Case
Generic Lipitor
News Headlines
RA Drug Trial
€105M Deal
South African IPO
News Headlines
HIV Infection
Amgen Application
NuPathe IPO
News Headlines
Spanish Savings
Industry Expansion
Astellas buys OSI
News Headlines
Pharma Slump
Emerging Markets
Life Science
News Headlines
Stem Cell Research
Bat Research
BioChicago Report
News Headlines
Anaemia Drugs
Implant Trials
COPD Therapies
News Headlines
GSK Alliance
Neglected Diseases
OTC Kit
News Headlines
Hepatitis C Case
Lung Drug Trial
Industry Outlook
News Headlines
Endo Acquisition
Drug Price Cuts
Genzyme Stock
News Headlines
J&J Medicines Plant
R&D Deal
Deal Restructured
News Headlines
US Approval Denied
New Trial Data
Q1 Results
News Headlines
Vimovo Approved
Valeant Buys Aton
Acurox Application
News Headlines
Angelini Labopharm
Financial Results
Provenge Approved
News Headlines
Cancer Research
GSK's Avandia
Tarceva Approved
News Headlines
Lucentis Study
Global Profits
AZ pays US$ 520M
News Headlines
EU Approval
Ipsen & Invida
Generic Launches
News Headlines
Sutent Trial Halts
US $1.6B Deal
Daxas Deal
News Headlines
NHS Can Pay Docs
Good News Bad News
Stomach Cancer
News Headlines
Novartis Approval
Genzyme Penalty
Lupus Drug Fails
News Headlines
Aisling Advice
Double Digit Rises
Discreet Deals
News Headlines
Market Forecast
Novartis Results
Deal Insight
News Headlines
Elan May Sell EDT
Genetic Mutations
Respiratory
News Headlines
Sanofi Trials
Vital Signs
Cancer Deal
News Headlines
Bribing Doctors
Genzyme Hopes
InterMune Success
News Headlines
Epilepsy Alert
BioTrinity 2010
Orexigen Blunder
News Headlines
Oral MS drug
Teva Tumour Deal
Roche Purchase
News Headlines
Fear Factor
Pfizer Trials
Malarone Settlement
News Headlines
Pixuvri Problems
Novartis and Alcon
Celgene Prospects
News Headlines
Forest Blow
Generics Approval
Pre-clinical Deal
News Headlines
Longevity Genes
Pfizer Optimistic
Multaq Blow
News Headlines
Depressed Pilots
Faster FDA Review
Accelrys & Symyx
News Headlines
Avodart Alert
Sanofi Investment
US$ 1.5B Deal
News Headlines
Gene Patent Blow
Boehringer Launch
Sanofi Diversifies
News Headlines
Lilly Looks East
GenVec Fails
Free Vaccines
News Headlines
Merck Strategy
Antisoma Crashes
MS Blood Test
News Headlines
HIV-Book
Better Delivery
Pfizer Guilty
News Headlines
Head-to-Head
Genzyme Watched
New Approaches
News Headlines
Hepatitis C Boost
Vaccine Problems
Vaccine Deal
News Headlines
James Black Dies
Plavix Plaudits
Rotarix Fears
News Headlines
Lung Cancer Gene
FDA Alert
Healthcare Reform
News Headlines
Seroquel Victory
Pay-For-Delay
Teva Buy Ratiopharm
News Headlines
Menveo Approval
MS Treatment
Cholesterol Hope
News Headlines
Cancer Tests
Missing Out
US$ 75M Raid
News Headlines
Medtronic vs. J&J
Diabetes Setback
Testosterone Boost
News Headlines
Double Trouble
Abbott Success
News Headlines
Beijing CMO
Allergan boost
Verdict on Pharma
News Headlines
HGS seeks mAbs
AZ in Torrent Deal
Lipids Warning
News Headlines
GSK Backs Cellzome
Novartis Cancer Bet
Abbott Buys Facet
News Headlines
Cancer Pain Success
Genmab Share Plunge
Animal Health JV
News Headlines
ratiopharm Wooed
AstraZeneca Cancer
Roche Drug Pulled
News Headlines
Winners & Losers
Cancer Trial
Vaxart Funding
News Headlines
Risk Aversion
Dimebon Study
Development Deal
News Headlines
Components & Trends
AstraZeneca Jobs Go
Archimedes
News Headlines
Volume & Value
AstraZeneca Buy
Astellas OSI Bid
News Headlines
Shire Shares Rise
Merck KGaA Deal
Financial Crisis
News Headlines
Patent Cases
IPO Postponed
Boost For Roche
News Headlines
Pfizer Wins
Generic Drugs
Cephalon Purchase
News Headlines
Asian cancer pact
Global partnership
News Headlines
GSK's
AstraZeneca pays
Anthera floats,
News Headlines
GSK and FDA accused
Meningitis and MS
Undercutting
News Headlines
Tasigna
New approval for
Safety fears
News Headlines
Prostate prize
Briefing
FDA probes device
REMS program
News Headlines
Statins
Merck & Co.'s mixed
Lilly's Effient
News Headlines
Briefing
Vote of Confidence
Fake Drugs
Teva Triumph
News Headlines
Pig Cell Potential
Qualified Approval
Speed Reader
News Headlines
Blockbuster
Gaucher rivals
Generics? No
News Headlines
Safety improvements
Deep breaths
Four Legged Friends
News Headlines
Vindicated
Briefing
Diversification
Invalid
News Headlines
eCard Drugs
Briefing
Healthier Hearts
Rejected
News Headlines
Briefing
Warned
Double Vision
Stemming Cancer
News Headlines
PTV News: Feb 5th,
PTV News: Feb 4th,
PTV News: Feb 3rd,
PTV News: Feb 2nd,
PTV News: Feb 1st,
PTV News: Jan 29th,
PTV News: Jan 28th,
PTV News: Jan 27th,
PTV News: Jan 26th,
PTV News: Jan 25th,
PTV News: Jan 22nd,
PTV News: Jan 21st,
PTV News: Jan 20th,
PTV News: Jan 19,
PTV News: Jan 18,
PTV News: Jan 15,
PTV News: Jan 14,
PTV News: Jan 13,
PTV News: Jan 12,
PTV News: Jan 11,
PTV News: Jan 8,
PTV News: Jan 7,
PTV News: Jan 6,
PTV News: Jan 5,
PTV News: Jan 4,
The Future
Round Table
Action Shares
New Ways
And Finally...
PTV News: Dec 23,
PTV News: Dec 22,
PTV News: Dec 21,
PTV News: Dec 18,
PTV News: Dec 17,
PTV News: Dec 16,
PTV News: Dec 15,
PTV News: Dec 14,
PTV News: Dec 11,
PTV News: Dec 10,
PTV News: Dec 9,
PTV News: Dec 8,
PTV News: Dec 7,
PTV News: Dec 4,
PTV News: Dec 3,
PTV News: Dec 2,
PTV News: Dec 1,
PTV News: Nov 30,
PTV News: Nov 27,
PTV News: Nov 26,
PTV News: Nov 25,
PTV News: Nov 24,
PTV News: Nov 23,
PTV News: Nov 20,
PTV News: Nov 19,
PTV News: Nov 18,
PTV News: Nov 17,
PTV News: Nov 16,
PTV News: Nov 13,
PTV News: Nov 12,
PTV News: Nov 11,
PTV News: Nov 10,
PTV News: Nov 9,
PTV News: Nov 6,
PTV News: Nov 5,
PTV News: Nov 4,
PTV News: Nov 3,
PTV News: Nov 2,
PTV News: Oct 30,
PTV News: Oct 29,
PTV News: Oct 28,
PTV News: Oct 27,
PTV News: Oct 26,
PTV News: Oct 23,
PTV News: Oct 22,
PTV News: Oct 21,
PTV News: Oct 20,
PTV News: Oct 19,
PTV News: Oct 16,
PTV News: Oct 15,
PTV News: Oct 14,
PTV News: Oct 13,
PTV News: Oct 12,
PTV News: Oct 9,
PTV News: Oct 8,
PTV News: Oct 7,
PTV News: Oct 6,
PTV News: Oct 5,
PTV News: Oct 2,
PTV News: Oct 1,
PTV News: Sep 30,
PTV News: Sep 29,
PTV News: Sep 28,
PTV News: Sep 25,
PTV News: Sep 24,
PTV News: Sep 23,
PTV News: Sep 22,
PTV News: Sep 21,
PTV News: Sep 18,
PTV News: Sep 17,
PTV News: Sep 16,
PTV News: Sep 15,
PTV News: Sep 14,
PTV News: Sep 11,
PTV News: Sep 10,
PTV News: Sep 9,
PTV News: Sep 8,
PTV News: Sep 7,
PTV News: Sep 4,
PTV News: Sep 3,
PTV News: Sep 2,
PTV News: Sep 1,
PTV News: Aug 31,
PTV News: Aug 28,
PTV News: Aug 27,
PTV News: Aug 26,
PTV News: Aug 25,
PTV News: Aug 24,
PTV News: Aug 21,
PTV News: Aug 20,
PTV News: Aug 19,
PTV News: Aug 18,
PTV News: Aug 17,
PTV News Promo
Scroll: Next
PTV News Feed:
 

HOW TO ACCESS PTV NEWS REVIEW

For company-wide access, contact [email protected] or telephone +44(0)1865 332700.


FOLLOW US ON TWITTER:
 
Click here for our Twitter page